Palmitoyl hexapeptide-12: complete guide

Palmitoyl hexapeptide-12 is a cosmetic lipopeptide built on the elastin sequence VGVAPG. This guide covers its structure, naming, research and safety review.

Complete guide6 min read

Key takeaway

PubChem lists palmitoyl hexapeptide-12 at 737.0 g/mol, built on the sequence VGVAPG. In 2014 the Cosmetic Ingredient Review (CIR) Expert Panel concluded it is safe as used in cosmetics. That conclusion covers only the VGVAPG sequence.

At a glance

Article typeComplete guide
Regulatory statusCosmetic / topical“Palmitoyl hexapeptide-12 is a cosmetic ingredient, not an FDA-approved drug.” (this article)
ClassSkin & cosmetic
Body systemsSkin & connective tissue
Studies cited5 in this article · 5 across 1 article on Palmitoyl hexapeptide-12
Related productsCopper peptides and melanocortin fragments

Palmitoyl hexapeptide-12 is a cosmetic ingredient made by joining palmitic acid to a six-amino-acid peptide. That peptide is a repeating unit of elastin, a structural protein. This guide covers its structure, naming history, laboratory research and safety review. Sources were checked on November 17, 2026.

Quick answer: Palmitoyl hexapeptide-12 is palmitic acid linked to the elastin peptide Val-Gly-Val-Ala-Pro-Gly. The EU CosIng database lists its function as skin conditioning. Most research on it is cell, tissue or computer work. It is a cosmetic ingredient, not a drug.

Vitrapep does not sell palmitoyl hexapeptide-12; this page is a reference summary of published research and regulatory information.

What is palmitoyl hexapeptide-12?

Palmitoyl hexapeptide-12 is a lipopeptide: a short peptide joined to a fatty acid. CosIng defines it as “the product of the reaction of palmitic acid and Hexapeptide-12” (CosIng, 2026). The peptide part is valine, glycine, valine, alanine, proline and glycine, written VGVAPG. PubChem lists the formula C38H68N6O8 and a molecular weight of 737.0 g/mol (PubChem CID 10212452). Our peptide primer explains how amino acids link into chains.

The name has a history. CIR explains that the older name “palmitoyl oligopeptide” was retired because it was vague and covered two ingredients. Those are now called palmitoyl tripeptide-1 (GHK) and palmitoyl hexapeptide-12 (VGVAPG). The ingredient dictionary lists two possible sequences for hexapeptide-12, and CIR’s review addresses only VGVAPG (CIR, 2014).

PubChem lists Biopeptide EL as a synonym. CIR describes Biopeptide EL and Dermaxyl as trade-name materials that contain palmitoyl hexapeptide-12. The GHK half of the old name has its own guide: palmitoyl tripeptide-1.

Table 1

Palmitoyl hexapeptide-12: key facts

Fact Detail
INCI name Palmitoyl Hexapeptide-12 (formerly part of “palmitoyl oligopeptide”)
Structure type Lipopeptide: palmitoyl group on a linear six-amino-acid peptide
Sequence Pal-Val-Gly-Val-Ala-Pro-Gly (Pal-VGVAPG)
Molecular formula C38H68N6O8
Molecular weight 737.0 g/mol
Main cosmetic function (CosIng) Skin conditioning
Trade name(s) Biopeptide EL; also a component of Dermaxyl

How does palmitoyl hexapeptide-12 work?

The idea comes from elastin biology. In 1984, Senior and colleagues showed that synthetic VGVAPG attracted fibroblasts and monocytes in laboratory chemotaxis assays. An antibody against elastin blocked this effect. The authors concluded that small synthetic peptides can reproduce the chemotactic activity of elastin fragments (Senior et al., 1984). This was in vitro cell work.

The palmitoyl group makes the peptide more fat-soluble. A 2020 review states that this fatty chain enhances skin permeation (Errante et al., 2020). That review groups the ingredient with “signal peptides,” which it describes as able to modulate skin protein turnover.

CIR summarized other laboratory effects of the VGVAPG sequence. They include more pro-collagenase-1 in skin fibroblasts and elastase release from white blood cells. In a chick embryo membrane model, palmitoyl hexapeptide-12 enhanced blood vessel growth (CIR, 2014). None of these findings show what a finished product does on human skin.

What is palmitoyl hexapeptide-12 used for?

CosIng lists one function for palmitoyl hexapeptide-12: skin conditioning. CIR likewise says the ingredients in its group “function primarily as skin conditioning agents.” In 2014, CIR reported that palmitoyl hexapeptide-12 was used in leave-on products, including body and hand sprays.

It appears on ingredient lists under its INCI name or inside trade-name blends. Under US law, intended use decides whether a product is a cosmetic or a drug. Claims to treat disease or to affect the structure or function of the body make a product a drug (FDA, 2024).

What does the research show?

Most published work on this ingredient is laboratory, tissue or computer research. We found no peer-reviewed, placebo-controlled human trial of palmitoyl hexapeptide-12 on its own.

Skin penetration (ex vivo). A team from the University of Nottingham, Binghamton University and a cosmetics company studied full-thickness human skin. OrbiSIMS mass spectrometry tracked the peptide into the stratum corneum and epidermis. The authors reported that it formed a gel there using ions already present in skin. They also reported that it helped strengthen and repair the skin barrier after lipids were stripped (Ligorio et al., 2025). The authors declared no competing financial interest.

Computer safety screen. Scientists at a consumer-products company ran seven peptides through six sequence-analysis tools. Palmitoyl hexapeptide-12 matched skin matrix proteins such as collagen, elastin and fibronectin. It did not raise the toxin concerns flagged for amanitin and a conotoxin in the same test set (Bjerke et al., 2026). The authors disclosed that their employer makes products containing some of the peptides studied.

Human patch tests. The CIR report describes tests on trade-name materials. They measured irritation and allergy, not appearance, and are covered in the next section.

What safety data exist?

The CIR Expert Panel reviewed palmitoyl hexapeptide-12 together with tripeptide-1, palmitoyl tetrapeptide-7 and related ingredients. Its final report, released June 30, 2014, concluded they are “safe in the present practices of use and concentration in cosmetics” (CIR, 2014). The report was later published in the International Journal of Toxicology (Johnson et al., 2018). Data in the report include:

  • Biopeptide EL did not irritate rabbit eyes or rabbit skin in single-application tests.
  • A diluted Dermaxyl sample caused no irritation or sensitization in a repeated insult patch test on 53 adult volunteers.
  • The same material was rated very well tolerated in a single patch test on 10 volunteers.
  • No reproductive, developmental or cancer studies were found in the published literature.

The Panel noted one finding from other research: hexapeptide-12 showed chemotactic activity toward tumor cells in laboratory studies. It still judged the group safe, citing low use levels and negative safety test data. The conclusion applies only to the VGVAPG sequence. CosIng lists no EU restrictions and no SCCS opinion for this ingredient.

What is palmitoyl hexapeptide-12’s regulatory status, and how is it used in research?

In the United States, cosmetic products and ingredients, other than color additives, need no FDA approval before sale (FDA, 2025). Palmitoyl hexapeptide-12 is a cosmetic ingredient, not an FDA-approved drug.

The Modernization of Cosmetics Regulation Act of 2022 (MoCRA) became law on December 29, 2022. It added facility registration, product listing, serious adverse event reporting, safety substantiation records and mandatory recall authority (FDA Voices, 2026). In the EU, CosIng lists the ingredient under CAS 171263-26-6 with an active status.

In research, the ingredient often serves as a model compound. Ligorio and colleagues used it to benchmark label-free methods for tracking cosmetic peptides in skin. Bjerke and colleagues used it as a test case for their peptide safety framework. For the wider class, see peptides in skincare.

Frequently asked questions about palmitoyl hexapeptide-12

Is palmitoyl hexapeptide-12 a peptide?

Yes. It is a six-amino-acid peptide (VGVAPG) carrying a palmitoyl fatty acid group, which makes it a lipopeptide.

Is it the same as palmitoyl oligopeptide?

Partly. CIR says the retired name palmitoyl oligopeptide covered two ingredients. One is now palmitoyl hexapeptide-12 and the other is palmitoyl tripeptide-1.

What is Biopeptide EL?

It is a trade-name material that PubChem lists as a synonym of palmitoyl hexapeptide-12. CIR describes it as containing the palmitoylated VGVAPG peptide.

Is palmitoyl hexapeptide-12 approved by the FDA?

No. FDA does not approve cosmetic ingredients, other than color additives, before they go on the market.

Is it the same as Matrixyl?

No. Matrixyl is palmitoyl pentapeptide-4, a different peptide sequence. See our Matrixyl guide.

What to know now

  • Structure: palmitic acid on the elastin peptide VGVAPG; C38H68N6O8; 737.0 g/mol.
  • Name: once part of “palmitoyl oligopeptide”; trade name Biopeptide EL.
  • Function: CosIng lists skin conditioning.
  • Evidence: in vitro chemotaxis (1984) and ex vivo skin imaging (2025); no placebo-controlled trial of the peptide alone found.
  • Safety: CIR found it safe as used in 2014, for the VGVAPG sequence only.
  • Status: a cosmetic ingredient, not an FDA-approved drug.

What we’re watching

FDA rules under MoCRA. The MoCRA page, updated October 29, 2026, lists good manufacturing practice and fragrance allergen labeling rules that the law requires (FDA, 2026). Related guides: palmitoyl tetrapeptide-7 and GHK-Cu.

More for skin & connective tissue

All 23 compounds for skin & connective tissue

Sources: National Center for Biotechnology Information 2026, PubChem compound summary for CID 10212452, palmitoyl hexapeptide-12; European Commission 2026, CosIng: Palmitoyl hexapeptide-12; Cosmetic Ingredient Review 2014; Johnson 2018, International Journal of Toxicology, 37; Senior 1984, Journal of Cell Biology, 99; Errante 2020, Frontiers in Chemistry, 8; Ligorio 2025, ACS Applied Bio Materials, 8; Bjerke 2026, Current Research in Toxicology, 10; U.S. Food and Drug Administration 2025, FDA authority over cosmetics: How cosmetics are not FDA-approved, but are FDA-regulated; U.S. Food and Drug Administration 2024, Is it a cosmetic, a drug, or both? (Or is it soap?); Kozlowski 2026, How FDA is implementing landmark cosmetics legislation to positively impact public health; U.S. Food and Drug Administration 2026, Modernization of Cosmetics Regulation Act of 2022 (MoCRA). All 12 citations

Back to the research library

References

  1. National Center for Biotechnology Information. (2026). PubChem compound summary for CID 10212452, palmitoyl hexapeptide-12. Retrieved November 17, 2026, from https://pubchem.ncbi.nlm.nih.gov/compound/10212452
  2. European Commission. (2026). CosIng: Palmitoyl hexapeptide-12 (substance ID 85666). Retrieved November 17, 2026, from https://ec.europa.eu/growth/tools-databases/cosing/details/85666
  3. Cosmetic Ingredient Review. (2014, June 30). Safety assessment of tripeptide-1, hexapeptide-12, their metal salts and fatty acyl derivatives, and palmitoyl tetrapeptide-7 as used in cosmetics (final report). https://www.cir-safety.org/sites/default/files/tripep062014final.pdf
  4. Johnson, W., Jr., et al. (2018). Safety assessment of tripeptide-1, hexapeptide-12, their metal salts and fatty acyl derivatives, and palmitoyl tetrapeptide-7 as used in cosmetics. International Journal of Toxicology, 37(3 suppl), 90S-102S. https://doi.org/10.1177/1091581818807863
  5. Senior, R. M., et al. (1984). Val-Gly-Val-Ala-Pro-Gly, a repeating peptide in elastin, is chemotactic for fibroblasts and monocytes. Journal of Cell Biology, 99(3), 870-874. https://doi.org/10.1083/jcb.99.3.870
  6. Errante, F., et al. (2020). Cosmeceutical peptides in the framework of sustainable wellness economy. Frontiers in Chemistry, 8, 572923. https://doi.org/10.3389/fchem.2020.572923
  7. Ligorio, C., et al. (2025). Noninvasive monitoring of palmitoyl hexapeptide-12 in human skin layers: Mechanical interaction with skin components and its potential skincare benefits. ACS Applied Bio Materials, 8(3), 2340-2355. https://doi.org/10.1021/acsabm.4c01816
  8. Bjerke, D. L., et al. (2026). A framework for the safety evaluation of peptides in cosmetics. Current Research in Toxicology, 10, 100291. https://doi.org/10.1016/j.crtox.2026.100291
  9. U.S. Food and Drug Administration. (2025). FDA authority over cosmetics: How cosmetics are not FDA-approved, but are FDA-regulated (content current as of 11/18/2025). Retrieved November 17, 2026, from https://www.fda.gov/cosmetics/cosmetics-laws-regulations/fda-authority-over-cosmetics-how-cosmetics-are-not-fda-approved-are-fda-regulated
  10. U.S. Food and Drug Administration. (2024). Is it a cosmetic, a drug, or both? (Or is it soap?) (content current as of 09/11/2024). Retrieved November 17, 2026, from https://www.fda.gov/cosmetics/cosmetics-laws-regulations/it-cosmetic-drug-or-both-or-it-soap
  11. Kozlowski, S. (2026). How FDA is implementing landmark cosmetics legislation to positively impact public health. FDA Voices, U.S. Food and Drug Administration. Retrieved November 17, 2026, from https://www.fda.gov/news-events/fda-voices/how-fda-implementing-landmark-cosmetics-legislation-positively-impact-public-health
  12. U.S. Food and Drug Administration. (2026). Modernization of Cosmetics Regulation Act of 2022 (MoCRA) (content current as of 10/29/2026). Retrieved November 17, 2026, from https://www.fda.gov/cosmetics/cosmetics-laws-regulations/modernization-cosmetics-regulation-act-2022-mocra